Takehiko Mori

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 412 publications

Successful Treatment with Epcoritamab for Refractory Diffuse Large B-cell Lymphoma in a Dialysis-dependent Patient.

Successful Treatment with Epcoritamab for Refractory Diffuse Large B-cell Lymphoma in a Dialysis-dependent Patient.

Journal: Internal medicine (Tokyo, Japan)

Published: July 20, 2026

Preface

Preface

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: July 08, 2026

Delayed-onset parkinsonism possibly associated with elranatamab treatment for relapsed/refractory multiple myeloma: a case report of a poorly characterized neurological event.

Delayed-onset parkinsonism possibly associated with elranatamab treatment for relapsed/refractory multiple myeloma: a case report of a poorly characterized neurological event.

Journal: Annals of hematology

Published: April 30, 2026

Seeing the invisible: practical strategies to maximize the clinical impact of photon-counting CT in abdominal imaging.

Seeing the invisible: practical strategies to maximize the clinical impact of photon-counting CT in abdominal imaging.

Journal: Abdominal radiology (New York)

Published: April 28, 2026

Evaluation of the UK Myeloma Research Alliance risk profile in transplant-ineligible multiple myeloma patients treated with novel agents.

Evaluation of the UK Myeloma Research Alliance risk profile in transplant-ineligible multiple myeloma patients treated with novel agents.

Journal: British journal of haematology

Published: February 21, 2026

Elranatamab treatment in a refractory multiple myeloma patient on maintenance hemodialysis

Elranatamab treatment in a refractory multiple myeloma patient on maintenance hemodialysis

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: February 01, 2026

Clinical features and prognostic factors of adult systemic chronic active EBV disease: A retrospective analysis in Japan.

Clinical features and prognostic factors of adult systemic chronic active EBV disease: A retrospective analysis in Japan.

Journal: British journal of haematology

Published: January 01, 2026

Induction chemotherapy with methotrexate, nimustine, and procarbazine for primary CNS lymphoma in the elderly: a retrospective evaluation of safety and efficacy.

Induction chemotherapy with methotrexate, nimustine, and procarbazine for primary CNS lymphoma in the elderly: a retrospective evaluation of safety and efficacy.

Journal: Journal of neuro-oncology

Published: December 12, 2025

Short- and mid-term outcomes of transanal/transperineal minimally invasive surgery for locally recurrent rectal cancer.

Short- and mid-term outcomes of transanal/transperineal minimally invasive surgery for locally recurrent rectal cancer.

Journal: Techniques in coloproctology

Published: November 25, 2025

Outcomes of allogeneic hematopoietic stem cell transplantation for acquired pure red cell aplasia.

Outcomes of allogeneic hematopoietic stem cell transplantation for acquired pure red cell aplasia.

Journal: International journal of hematology

Published: November 03, 2025

Paroxysmal Nocturnal Hemoglobinuria in Patients with Systemic Lupus Erythematosus: Diagnostic Challenges and Improvement with C5 Inhibitor Treatment.

Paroxysmal Nocturnal Hemoglobinuria in Patients with Systemic Lupus Erythematosus: Diagnostic Challenges and Improvement with C5 Inhibitor Treatment.

Journal: Internal medicine (Tokyo, Japan)

Published: October 22, 2025

Reduced-Dose Bendamustine as a First-Line Treatment of Follicular Lymphoma Is Associated With Poorer Prognosis.

Reduced-Dose Bendamustine as a First-Line Treatment of Follicular Lymphoma Is Associated With Poorer Prognosis.

Journal: Cancer medicine

Published: October 08, 2025

Showing 1-12 of 412

Last Updated: 09/26/2026